Chronic Necrotizing Aspergillosis: A New Risk with Teriflunomide in Multiple Sclerosis Patients? - Sorbonne Université Access content directly
Journal Articles REVUE NEUROLOGIQUE Year : 2022
No file

Dates and versions

hal-03793522 , version 1 (01-10-2022)

Identifiers

Cite

Valérie Pourcher, Jennifer Yeung, Françoise Le Pimpec-Barthes, Elisabeth Maillart, Laure Gibault, et al.. Chronic Necrotizing Aspergillosis: A New Risk with Teriflunomide in Multiple Sclerosis Patients?. REVUE NEUROLOGIQUE, 2022, 178 (3), pp.266--267. ⟨10.1016/j.neurol.2021.06.012⟩. ⟨hal-03793522⟩
15 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More